Font Size: a A A
Keyword [Silico]
Result: 1 - 20 | Page: 1 of 5
1. In Silico Modeling Of ADME
2. Immunoproteomics Of Bordetella Pertussis And In Silico Search For Novel Vaccine Candidates And Drug Targets Against Pertussis
3. In Silico Analysis And Verification Of S100 Gene Expression In Gastric Cancer
4. Screening And Functional Studies Of Novel Tumor Markers
5. Expression Profile-based In Silico Screening Of Candidate Therapeutic Compounds For Lung Adenocarcinoma And Related Experiments
6. Establishing An In Silico Model To Predict The Effect Of Ivabradine On The Probability Of Coronary Plaque Rupture
7. Rational Optimization Of Tumor Epitopes Using In Silico Analysis Assisted Substitution Of TCR Contact Residues
8. Establishing An In Silico Model To Predict The Modification Of Systolic Blood Pressure Reaction To Pharmacological Intervention
9. Methodology Development Of In Silico ADMET Prediction And Drug Design Targeting Estrogen Receptors
10. Expression-based In Silico Screening Of Candidate Therapeutic Drugs For Liver Fibrosis And Related Experiment
11. In Silico Prediction And Their Preliminary Identification Trial In Vivo Of T Cell Epitopes In Secretory Antigens Of Schistosoma Japonicum
12. Application Of Bioinformatics Method In Facilitating The Prediction Of Adverse Drug Reaction
13. Cloning And Bioinformatics Analysis Of EST Associated With Gastric Carcinoma On Chromosome 8p21
14. Antitumor Study In Silico And Synthesis Of Honokiol Derivatives Based On Virtual Screening
15. Prediction On The BA/BE Of Drugs And Their Formulations Using In Silico/in Vitro Model Based On BCS
16. Small Molecular Antagonists Screening For Ubiquitin Ligase Smurf1and Compounds’ Function Investigation
17. In Silico Chemical Toxicity Prediction Models And The Prediction Of Risk Of Tobacco And Tobacco Smoke Components
18. In Silico Prediction Of Drug Metabolism And Renal Transporters-Mediated Elimination, And Discovery Of Inhibitors Targeting The Menin-Mixed Lineage Leukaemia(MLL) Interface
19. In Silico Screening Of Oncogene CDK2 Inhibitors And Validation As A Potential Anti-cancer Drugs
20. The Construction Of In Silico Chemical Mutagenicity Models And Quantitative Regressive Workflow
  <<First  <Prev  Next>  Last>>  Jump to